Ambusol AB (publ)
559465-8303ActivePioneering patented therapy to eradicate residual glioblastoma cells post-surgery.
Översikt
- 1–4
- Anställda
- 100–149t SEK
- Omsättning
- 2023
- Grundat
Nyckelbeslutsfattare
Göran Ronquist
Founder and board member
Owe Orwar
Senior Adviser to the board
Frederic Telander
Founder and chairman of the board
Holger Ronquist
Founder and board member
+2 fler kontakter i Funnelfeedr
Beskrivning
Ambusol is a clinical-stage cancer therapeutics company focused on revolutionizing the treatment of glioblastoma (GBM). Their core mission is to eradicate residual GBM cells remaining in the surgical margins after operation, offering new hope to patients. The company pioneers a patented approach uti...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Tillverkning av läkemedel
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559465830301
Beslutsfattare
6 kontakter i FunnelfeedrGöran Ronquist
Founder and board member
Owe Orwar
Senior Adviser to the board
Frederic Telander
Founder and chairman of the board
Holger Ronquist
Founder and board member
Maximilian Telander
CEO, founder and board member
Gunnar Ronquist
Founder and board member
Liknande företag
20 liknande företag i FunnelfeedrIsofol Medical AB (publ)
10–19 anställdaDeveloping next-generation folate drug to improve cancer treatment efficacy.
AcroPharma AB (publ)
0 anställdaDeveloping innovative preventive therapeutics for major human diseases.
Mendus AB (publ)
Developing immune-based cancer therapies to prevent recurrence.
Akiram Therapeutics AB
1–4 anställdaPioneering targeted radioimmunotherapy to treat incurable solid tumors effectively.
AAX Biotech AB
5–9 anställdaResearch-driven biotech advancing antibody therapies via proprietary technology.
Utforska mer
Frågor om Ambusol AB (publ)
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo